University of Toronto Mississauga
UTM Gunning Group Fund
The innovative work being done by the UTM Gunning Group will revolutionize cancer treatment as we know it today. Professor Patrick Gunning and his team are developing less toxic, molecularly targeted anti-cancer therapeutics that will silence cancer-promoting proteins. Support for the UTM Gunning Group Fund will yield innovative research in novel molecular therapeutics resulting in viable, highly effective and targeted treatment of a range of diseases.